Abstract
Introduction
Vasomotion is the regular variation in tone of arteries. Vasomotion, e.g. oscillations of vascular tone due to synchronized oscillations of smooth muscle cell tension, occurs in arteries either spontaneously or in response to pressure, stretch or application of vasoconstrictor agonists [1] [2] [3] . Vasomotion is known to be associated with slow oscillations of smooth muscle membrane potential and of intracellular calcium concentrations. Vasomotion may also be enhanced by oscillations of transplasmamembrane calcium influx [4] [5] [6] . In several experimental models of hypertension an increased vasomotion of arteries had been described. Lefer [7] . An [8, 9] . Transient receptor potential canonical (TRPC) cation channels have been described to play an important role for transplasmamembrane calcium influx [10] . Recent experimental data from our group and other groups indicated that an increased TRPC expression is associated with hypertension. Liu et al. reported increased TRPC3 expression in several tissues from SHR compared to normotensive WKY rats [11, 12] . Dietrich et al. showed that elevated TRPC3 channel expression in TRPC6 knockout mice was associated with increased vasoconstriction and increased blood pressure [13] .
et al. observed enhanced vasomotion of cerebral arterioles in spontaneously hypertensive rats (SHR) compared to normotensive rats
In the present study we therefore tested the hypothesis whether increased vasomotion in hypertension is associated with increased TRPC expression in mesenteric arterioles from SHR. Our study for the first time gives several experimental evidence that TRPC channels are responsible for increased oscillations of vascular tone in hypertension. (NIH Publications No. 85-23, revised 1996) and was approved by the local animal protection authorities.
Materials and methods

The investigation conforms to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health
Animals and treatment
In this study, 3-month-old SHR and WKY rats weighing 250-260 g were used. SHR were randomly divided into four groups: control group received placebo (n ϭ 6), 5 mg/kg/day telmisartan (n ϭ 6), 4 mg/kg/day candesartan (n ϭ 6) and 10 mg/kg/day amlodipine (n ϭ 6) by oral garage for 16 weeks. WKY were used as reference controls (n ϭ 6) but were not treated with telmisartan, candisartan or amlodipine by oral garage. The rats were housed under a 12-hr/12-hr day/night cycle and given tap water and standard chow ad libitum. Systolic blood pressure was measured monthly in conscious and restrained rats by the tail-cuff method. 
Preparation of mesenteric arterioles and measurements of isometric tension
Immunoblotting
Immunoblotting was performed as previously described by our group [11, 12] 
Statistics
Data are given as mean Ϯ S.E.M. Statistical analyses of the data were performed with the two-tailed Student's t-test for unpaired comparisons.
Analysis of data ANOVA was used, because vasomotion was investigated in several unrelated vessels when comparing more than two groups. Values were considered to be significant when two-sided P was less than 0.05.
Results
Increased norepinephrine-induced vasomotion in mesenteric arterioles from SHR
After administration of 10 mol/l norepinephrine a rapid vasoconstriction was followed by synchronized oscillations of vascular tone, i.e. vasomotion, in mesenteric arterioles from WKY ( Fig. 1A) and SHR (Fig. 1B) . Norepinephrine-induced vasomotion was quantified as percentages of oscillations of vascular tone in relation to the maximal contraction to KCl. (Fig. 1C) . The norepinephrine-induced vasomotion was significantly higher in mesenteric arterioles from SHR compared to WKY (65.5 Ϯ 7% versus 2.2 Ϯ 0.5%; each n ϭ 6, P Ͻ 0.01). The norepinephrine-induced vasoconstriction was also significantly increased in mesenteric arterioles from SHR compared to WKY (140 Ϯ 11% versus 100 Ϯ 3%; each n ϭ 6, P Ͻ 0.05, Fig. 1D ). Recordings for more than 1 hr confirmed increased norepinephrine-induced vasomotion in SHR compared to WKY (Fig. 1E and F Fig. 3 , compared to control conditions (57.0 Ϯ 6%, n ϭ 6, Fig. 3A) , the norepinephrine-induced vasomotion was significantly reduced in the presence of several chemically unrelated TRPC blockers, i.e. in the presence of gadolinium reduced to 48.5 Ϯ 6% (Fig. 3B) , in the presence of 2-APB reduced to 30.3 Ϯ 3% (Fig. 3C ) and in the presence of SKF96365 reduced to 23.5 Ϯ 9% (Fig. 3D) (each n ϭ 6; *P Ͻ 0.05 or **P Ͻ 0.01 by ANOVA, Fig. 3I (43.0 Ϯ 15%; P ϭ n.s.; n ϭ 6, Fig. 4D ). In the presence of anti-TRPC5 antibodies the norepinephrine-induced vasomotion was not significantly affected (45.0 Ϯ 11%; P ϭ n.s. Fig. 4E ). In the presence of anti-TRPC1 plus anti-TRPC3 antibodies the norepinephrine-induced vasomotion was significantly reduced to 29.0 Ϯ 8% (P Ͻ 0.05; n ϭ 6, Fig. 4F) [17] . The magnitude of vasomotion of the maximal contraction to KCl was 57.6 Ϯ 5% under control conditions with isotonic NaCl, it was 54.0 Ϯ 7% under control conditions after short-term exposure to hypotonic 0.45% NaCl without antibody, and it was 23.4 Ϯ 4% after short-term exposure to hypotonic 0.45% NaCl plus TRPC3 antibody (P Ͻ 0.01.; n ϭ 6, Fig. 4H-J) .
Inhibition of TRPC significantly attenuates norepinephrine-induced vasomotion in SHR
Fig. 1 Comparison of vasomotion induced by norepinephrine (10 mol/l) in mesenteric arterioles from WKY (A) and SHR (B). (C) Summary data for norepinephrine-induced vasomotion in mesenteric arterioles from SHR (filled bars) compared with WKY (open bars). (D) Summary data for norepinephrine-induced vasoconstriction in mesenteric arterioles from SHR (filled bars) compared with WKY (open bars
. Furthermore, pre-incubation of mesenteric arterioles with anti-␤-actin antibodies did not significantly affect norepinephrine-induced vasomotion when compared to control conditions (59.8 Ϯ 15%, P ϭ n.s.; n ϭ 6, Fig. 4G). Incorporation of TRPC antibodies into mesenteric arteries by pinocytosis was facilitated by changing the bathing solution to a hypotonic solution according to recent literature
Control experiments were performed to underline the significance of using TRPC antibodies for inhibition of norepinephrineinduced vasomotion. First, destruction of the antibody by heating abolished its effects on vasomotion. After heating of the anti-TRPC3 antibody to 95ЊC for 5 min. no effect on norepinephrineinduced vasomotion could be observed (58.0 Ϯ 7% versus 56.3 Ϯ 5%, each n ϭ 6; P Ͼ 0.05). Second, we compared TRPC antibodies supplied from different sources. Additional experiments using
Fig. 3 Inhibition of TRPC significantly attenuates norepinephrine-induced vasomotion in SHR. Vasomotion was induced by norepinephrine after depletion of sarcoendoplasmic reticulum calcium stores by 1 mol/l thapsigargin (TG) in mesenteric arterioles from SHR under control conditions (A), in the presence of gadolinium (Gd 3ϩ ) (B), 2-APB (C) or SKF96365 (D), in the presence of verapamil (E), or in the presence of verapamil plus Gd 3ϩ (F), verapamil plus 2-APB (G) or verapamil plus SKF96365 (H). (I) Summary data are shown as mean Ϯ S.E.M. of n ϭ 6 independent experiments
. *P Ͻ 0.05 or **P Ͻ 0.01 by ANOVA. Fig. 5A ). In the presence of anti-TRPC3 antibodies, the norepinephrine-induced calcium increase was significantly reduced to 188 Ϯ 37 nmol/l (P Ͻ 0.05; n ϭ 8, Fig. 5B ). In the presence of anti-TRPC5 antibodies, the norepinephrine-induced calcium increase was significantly reduced to 185 Ϯ 48 nmol/l (P Ͻ 0.05; n ϭ 8, Fig. 5C ). In the presence of anti-TRPC1 plus anti-TRPC3 and anti-TRPC5 antibodies the norepinephrine-induced calcium increase was significantly reduced to 100 Ϯ 18 nmol/l (P Ͻ 0.01; n ϭ 8, Fig. 5D) Fig. 5F ). Fig. 6(C)-(F) .
Fig. 4 Inhibition of norepinephrine-induced vasomotion in mesenteric arterioles from SHR by specific anti-TRPC antibodies Representative tracings of norepinephrine-induced vasomotion in mesenteric arterioles from SHR under control conditions (A), in the presence of anti-TRPC1 antibodies (B), anti-TRPC3 antibodies (C), anti-TRPC3 antibodies with antigenic peptide (D), anti-TRPC5 antibodies (E), anti-TRPC1 plus anti-TRPC3 antibodies (F) or in the presence of anti-␤-actin antibodies (G). Representative tracings of norepinephrine-induced vasomotion in mesenteric arterioles from SHR under control conditions after short-term exposure to hypotonic 0.45% NaCl without antibody (H), or after short-term exposure to hypotonic 0.45% NaCl plus TRPC3 antibody (I). Summary data (J) show that inhibition of TRPC channels by specific anti-TRPC antibodies significantly attenuates norepinephrineinduced vasomotion in SHR. Data are mean Ϯ S.E.M. of n
Inhibition of norepinephrine-induced calcium increase in mesenteric arterioles from SHR by specific TRPC antibodies
We further evaluated the effects of specific anti-TRPC antibodies on norepinephrine-induced calcium increase in mesenteric arterioles. As shown in Fig. 5, under control conditions, the norepinephrine-induced calcium increase in mesenteric arterioles was 299 Ϯ 20 nmol/l (n ϭ 8). In the presence of anti-TRPC1 antibodies, the norepinephrine-induced calcium increase was significantly reduced to 150 Ϯ 31 nmol/l (P Ͻ 0.01; n ϭ 8,
Effect of candesartan or telmisartan but not amlodipine on the rhythmic oscillatory vasomotion of mesenteric arterioles
Effect of candesartan or telmisartan but not amlodipine on TRPC expression in mesenteric arterioles
As shown in Fig. 7 [1] . On the other hand, increased vasomotion may be responsible for development and maintenance of pathophysiological states including hypertension [2] . The present study confirmed previous reports showing increased vasomotion in hypertension [7] [8] [9] . Earlier genetic studies based on crossbreeding showed a close association between hypertension and increased oscillations of arterial vascular tone [21, 22] [22] [23] [24] . TRPC1, TRPC3 and TRPC5 channels have been reported to form second-messenger-operated calcium entry channels [22] [23] [24] . Furthermore, TRPC1, TRPC3 and TRPC5 channels show also characteristics of store-operated TRP channels [25] [26] [27] [28] .
Subsequent calcium influx or oscillatory release of calcium from intracellular stores then activates calcium-dependent chloride channels which intermittently depolarize the membrane potential [1, 2] . Depolarization and calcium influx through voltage-dependent calcium channels has been shown to be an important step in coordinating the individual oscillators for example in rat mesenteric arteries [29] . Hence, the increased expression of TRPC channels in rat mesenteric arteries may be the initial trigger for increased [5] .
Representative tracings of norepinephrineinduced calcium increase in mesenteric arterioles from SHR under control conditions and in the presence of anti-TRPC1 antibodies (A), anti-TRPC3 antibodies (B), anti-TRPC5 antibodies (C), anti-TRPC1 plus anti-TRPC3 plus anti-TRPC5 antibodies (D), anti-TRPC3 antibodies plus TRPC3 antigenic peptide (E) or anti-␤-actin antibodies (F). Summary data (G) shows the effects of specific anti-TRPC antibodies on norepinephrine-induced calcium influx in
We used several chemically unrelated TRPC blockers, including gadolinium, 2-APB, or SKF96365, as recently described by Rose et al. [30] . Several investigators reported that 2-APB or SKF-96365 are able to reduce cation influx through TRP channels [25, 31, 32] [15, 16] . Furthermore, they found that anti-TRPC1 antibodies produced marked inhibition of storeoperated calcium activity in mesenteric arteries [15, 16] . Now (Fig. 7A ) and summary data are shown (Fig. 7B ). *P Ͻ 0.05; **P Ͻ 0.01 compared with placebo by ANOVA.
